Downregulation of INSR signaling has been implicated in several neurodegenerative diseases [6], particularly Alzheimer’s disease [16–19], and INSR stimulation proposed as a potential treatment for neurodegenerative disorders [20]. The gene discussed is INSR; the disease is early-onset autosomal dominant Alzheimer disease.